P. Saleem

Long‐term safety and efficacy of amisulpride in subchronic or chronic schizophrenia

W. Rein, L. Colonna, P. Saleem, 2000 .

Long-term safety and efficacy of amisulpride in subchronic or chronic schizophrenia. Amisulpride Study Group.

W. Rein, L. Colonna, P. Saleem, 2000, International clinical psychopharmacology.

Social functioning and quality of life in the schizophrenic patient: advantages of amisulpride

H. Lôo, J. Olié, P. Saleem, 2002, International clinical psychopharmacology.

Randomised Controlled Trial of Day and In-patient Psychiatric Treatment. 2: Comparison of Two Hospitals

P. Thomas, D. Black, F. Creed, 1991, British Journal of Psychiatry.

Switching stable patients with schizophrenia from depot and oral antipsychotics to long‐acting injectable risperidone: reasons for switching and safety

M. Turner, C. Hawley, P. Saleem, 2010, Human psychopharmacology.

Switching to Long-Acting Injectable Risperidone is Beneficial with Regard to Clinical Outcomes, Regardless of Previous Conventional Medication in Patients with Schizophrenia

P. Glue, R. Medori, P. Saleem, 2007, European Psychiatry.